Literature DB >> 3260730

CT, MR, and pathology in HIV encephalitis and meningitis.

M J Post1, L G Tate, R M Quencer, G T Hensley, J R Berger, W A Sheremata, G Maul.   

Abstract

The value and limitations of CT and MR in human immunodeficiency virus (HIV) infection of the brain was determined by a retrospective analysis of the CT scans (22) and MR images (7) in 22 patients with pathologically proved HIV encephalitis (21) or meningitis (1). Our clinical-radiologic-pathologic correlation suggested that, especially in the early stages of the disease, CT and MR were relatively insensitive in detecting the primary changes of HIV encephalitis. The multiple bilateral diffuse microscopic glial nodules with multinucleated giant cells of HIV found at autopsy in both gray and white matter were usually not directly visualized by either CT or MR. Secondary, nonspecific changes, however, were seen. These included cortical atrophy, found in virtually all patients with HIV encephalitis, and HIV-induced foci of demyelination found in the minority of cases. On CT the latter were seen in the white matter as nonenhancing, nonmass-producing areas of low density; on MR they were seen as frequently progressive high-intensity signal abnormalities on T2-weighted images, usually in the periventricular white matter and centrum semiovale. MR was more sensitive in detecting these demyelinative lesions than was CT. The clinical diagnosis of HIV encephalitis usually antedated the radiographic diagnosis. In HIV meningitis, contrast CT was more definitive than MR, showing striking enhancement of the subarachnoid spaces, although MR was more sensitive in detecting the secondary parenchymal changes.

Entities:  

Mesh:

Year:  1988        PMID: 3260730     DOI: 10.2214/ajr.151.2.373

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 2.  Nuclear medicine applications in immunosuppressed patients, "AIDS".

Authors:  H M Abdel-Dayem
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

3.  Correlation of MRI and neuropathology in AIDS.

Authors:  I P Everall; W K Chong; I D Wilkinson; M N Paley; R J Chinn; M A Hall-Craggs; F Scaravilli; P L Lantos; P J Luthert; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

4.  Enhanced gray-white matter differentiation on non-enhanced CT using a frequency selective non-linear blending.

Authors:  Georg Bier; Malte Niklas Bongers; Hendrik Ditt; Benjamin Bender; Ulrike Ernemann; Marius Horger
Journal:  Neuroradiology       Date:  2016-03-10       Impact factor: 2.804

5.  Pathological findings correlated with MRI in HIV infection.

Authors:  C P Hawkins; J E McLaughlin; B E Kendall; W I McDonald
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

Authors:  M J Harrison; S P Newman; M A Hall-Craggs; C J Fowler; R Miller; B E Kendall; M Paley; I Wilkinson; B Sweeney; S Lunn; S Carter; I Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

Review 7.  Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).

Authors:  P Portegies
Journal:  Drugs       Date:  1995       Impact factor: 9.546

8.  CT and MRI: prognostic tools in patients with AIDS and neurological deficits.

Authors:  A Mundinger; T Adam; D Ott; E Dinkel; A Beck; H H Peter; B Volk; M Schumacher
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT.

Authors:  A Rubbert; E Bock; J Schwab; J Marienhagen; H Nüsslein; F Wolf; J R Kalden
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

10.  PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS.

Authors:  Sriram Venneti; Brian J Lopresti; Guoji Wang; Stephanie J Bissel; Chester A Mathis; Carolyn C Meltzer; Fernando Boada; Saverio Capuano; Geraldine J Kress; Denise K Davis; James Ruszkiewicz; Ian J Reynolds; Michael Murphey-Corb; Anita M Trichel; Stephen R Wisniewski; Clayton A Wiley
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.